Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5845738 | Pulmonary Pharmacology & Therapeutics | 2014 | 12 Pages |
Abstract
In chronic lung disorders such as in asthma and chronic obstructive pulmonary disease (COPD) there is increased bronchial angiogenesis and remodelling of pulmonary vessels culminating to altered bronchial and pulmonary circulation. The involvement of residential cells such as endothelial cells, smooth muscle cells and pulmonary fibroblasts, all appear to have a crucial role in the progression of vascular inflammation and remodelling. The regulatory abnormalities, growth factors and mediators implicated in the pulmonary vascular changes of asthma and COPD subjects and potential therapeutic targets have been described in this review.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Louise M. Harkness, Varsha Kanabar, Hari S. Sharma, Gunilla Westergren-Thorsson, Anna-Karin Larsson-Callerfelt,